Jason Lee, MD
Interventional Pain Medicine · Owensboro, KYNPI 1497073530
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 35.6% of the total. That places this record below the midpoint for interventional pain medicine clinicians in KY, where the typical reported total is $3,169.
Across 92 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$576
- Si-bone, Inc.$179
- Pfizer$140
- AbbVie$104
- Medtronic$79
- Amgen$53
- plus $485 from 18 others
What the payments were for
- Food & beverage$1,615100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 32 | $576 |
| Si-bone, Inc. | 7 | $179 |
| Pfizer | 10 | $140 |
| AbbVie(2 entities) | 5 | $104 |
| Medtronic(2 entities) | 6 | $79 |
| Amgen(2 entities) | 3 | $53 |
| Biodelivery Sciences International, Inc. | 4 | $48 |
| AstraZeneca | 3 | $44 |
| Avanos Medical | 2 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Nevro Corp. | 2 | $39 |
| Valinor Pharma, LLC | 2 | $38 |
| Lilly USA, LLC | 2 | $29 |
| Averitas Pharma Inc. | 1 | $24 |
| Abbott | 1 | $22 |
| Novo Nordisk | 1 | $22 |
| Shionogi Inc | 1 | $21 |
| Vertex | 1 | $20 |
| GRT US Holding, Inc. | 1 | $18 |
| Acacia Pharma Inc | 1 | $16 |
| Novartis | 1 | $16 |
| Vertos Medical, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Stryker | 1 | $13 |
How this compares
$1,615 in reported general payments places this provider in the 35th percentile of 55 interventional pain medicine providers in Kentucky.
See all interventional pain medicine providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 238 | $52,762 |
| BelbucaBuprenorphine Hcl | 66 | $48,293 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,845 | $42,761 |
| MovantikNaloxegol Oxalate | 48 | $28,151 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 716 | $17,965 |
| Gabapentin | 1,160 | $12,294 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 268 | $8,978 |
| Pregabalin | 226 | $7,422 |
| LyricaPregabalin | 12 | $6,418 |
| Tramadol Hcl ErTramadol Hcl | 85 | $6,316 |
| Oxycodone Hcl | 260 | $5,010 |
| Tizanidine Hcl | 439 | $4,227 |
| Lidocaine | 35 | $4,008 |
| OxycontinOxycodone Hcl | 11 | $3,460 |
| Morphine Sulfate ErMorphine Sulfate | 103 | $2,262 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $576 | $48,29366 claims |
| PfizerLyrica | $140 | $6,41812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 55 interventional pain medicine providers in Kentucky.
Other interventional pain medicine in Owensboro
- Cristina LamarOwensboro$2K
- Suk KimOwensboro$1K
- Robert KlickovichFlorence$57K
- Hammad MalikRichmond$35K
- Michael FletcherFlorence$18K
- Vishal BansalMadisonville$13K
- Anand ModaduguLexington$12K
- Zachary KlingerCorbin$10K
- Nathan LambornLouisville$10K
- Brock MarrsLexington$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.